Regulatory Impact

White House Secures Pfizer Deal on Drug Prices With TrumpRx Discounts and $70 Billion U.S. Investment

Tariff pressure yielded MFN Medicaid prices with direct-sale discounts, leaving the timing of consumer savings unclear.